Exact Mass: 591.0866522

Exact Mass Matches: 591.0866522

Found 19 metabolites which its exact mass value is equals to given mass value 591.0866522, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

trans-zeatin riboside triphosphate

9-ribosyl-trans-zeatin 5-triphosphate

C15H24N5O14P3 (591.0532594)


A purine ribonucleoside 5-triphosphate that is ATP substituted at position N-6 by a (2E)-4-hydroxy-3-methylbut-2-en-1-yl group.

   

UDP-2-acetamido-2,6-dideoxy-beta-L-talose

UDP-2-acetamido-2,6-dideoxy-beta-L-talose; UDP-N-acetyl-beta-L-pneumosamine

C17H27N3O16P2 (591.0866522)


   

UDP-N-acetyl-beta-L-fucosamine

UDP-N-acetyl-beta-L-fucosamine

C17H27N3O16P2 (591.0866522)


   
   

UDP-N-acetyl-D-quinovosamine

UDP-N-acetyl-D-quinovosamine

C17H27N3O16P2 (591.0866522)


   

UDP-N-acetyl-L-rhamnosamine

UDP-N-acetyl-L-rhamnosamine

C17H27N3O16P2 (591.0866522)


   
   
   
   
   

potassium 1-amino-4-[[3-[[(2-chloro-1-oxoallyl)amino]methyl]-2,4,6-trimethylphenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate

potassium 1-amino-4-[[3-[[(2-chloro-1-oxoallyl)amino]methyl]-2,4,6-trimethylphenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate

C27H23ClKN3O6S (591.0633108000001)


   

BX-795

N-[3-[[5-Iodo-4-[[3-[(2-thienylcarbonyl)amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide

C23H26IN7O2S (591.0913366)


   

Uridine 5-(trihydrogen diphosphate) P-(6-azido-6-deoxy-alpha-D-glucopyranosyl) ester

Uridine 5-(trihydrogen diphosphate) P-(6-azido-6-deoxy-alpha-D-glucopyranosyl) ester

C15H23N5O16P2 (591.0615018000001)


   

[(2S,3S,4R,5S,6S)-5-acetamido-3,4-dihydroxy-6-methyloxan-2-yl] [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate

[(2S,3S,4R,5S,6S)-5-acetamido-3,4-dihydroxy-6-methyloxan-2-yl] [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate

C17H27N3O16P2 (591.0866522)


   

[[3,4-dihydroxy-5-[6-[[(E)-4-hydroxy-3-methylbut-2-enyl]amino]purin-9-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate

[[3,4-dihydroxy-5-[6-[[(E)-4-hydroxy-3-methylbut-2-enyl]amino]purin-9-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate

C15H24N5O14P3 (591.0532594)


   

GSK2033

GSK2033

C29H28F3NO5S2 (591.1360914)


GSK2033 is a LXR antagonist with pIC50s of 7 and 7.4 for LXRα or LXRβ, respectively.

   

12,13,25,26-tetrahydroxy-8,9,9-trimethyl-7-oxa-27,28,29-trithia-3,16,18-triazaoctacyclo[12.12.3.0¹,¹⁶.0³,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁷,²⁵.0¹⁹,²⁴]nonacosa-6(10),19,21,23-tetraene-2,11,15-trione

12,13,25,26-tetrahydroxy-8,9,9-trimethyl-7-oxa-27,28,29-trithia-3,16,18-triazaoctacyclo[12.12.3.0¹,¹⁶.0³,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁷,²⁵.0¹⁹,²⁴]nonacosa-6(10),19,21,23-tetraene-2,11,15-trione

C25H25N3O8S3 (591.080373)


   

(1s,8r,13s,14s,17s,26s)-12,13,25,26-tetrahydroxy-8,9,9-trimethyl-7-oxa-27,28,29-trithia-3,16,18-triazaoctacyclo[12.12.3.0¹,¹⁶.0³,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁷,²⁵.0¹⁹,²⁴]nonacosa-6(10),19,21,23-tetraene-2,11,15-trione

(1s,8r,13s,14s,17s,26s)-12,13,25,26-tetrahydroxy-8,9,9-trimethyl-7-oxa-27,28,29-trithia-3,16,18-triazaoctacyclo[12.12.3.0¹,¹⁶.0³,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁷,²⁵.0¹⁹,²⁴]nonacosa-6(10),19,21,23-tetraene-2,11,15-trione

C25H25N3O8S3 (591.080373)